.Merck trumps profits requirements, increases purchases expectation on tough need for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Forecasts as Keytruda Purchases Rise BloombergMerck Supply: Pharma Giant Posts Tough Outcomes, Yet Overview Tumbles Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps earnings as well as sales assumptions amidst Keytruda strong point, but provides combined full-year outlook MarketWatch.